AzTrials
AzTrials

Ultra-Processed Food IntakePhase 2DISRUPTNCT07226336

Dietary Interventions to Reduce Ultra-Processed Food Intake

A Phase 2 study testing Introductory Educational Workshop, Standard Dietary Change (ON/OFF) and Cognitive Dissonance Strategies (ON/OFF) in people with Ultra-Processed Food Intake and Obesity & Overweight, run by Oregon Research Institute at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The DISRUPT clinical trial will test two different 2-month programs to help adults with overweight/obesity (N=60) reduce their intake of ultra-processed foods (UPFs). Participants will be randomly assigned to receive standard dietary change strategies, cognitive dissonance strategies that engage them in activism… Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Introductory Educational Workshop, Standard Dietary Change (ON/OFF) and Cognitive Dissonance Strategies (ON/OFF)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
59 participants
Where
1 siteUnited States
Study dates
10 Feb 2026to 31 Jul 2026
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ages 18-70 years old
  • BMI >25 and <50 kg/m2
  • Wish to reduce their UPF intake
  • Consume at least 2 UPF items per day and at least 4 distinct UPF items per week

Who cannot join

  • Have ever been diagnosed with anorexia nervosa or bulimia nervosa
  • Are using medications known to influence eating behavior and/or weight (e.g., semaglutide)
  • Currently using insulin
  • History of bariatric surgery
  • Current pregnancy or planning to become pregnant during the study period

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Oregon Research Institute

    Springfield, Oregon, 97477

Other trials in United States

About this study

Official title: Testing a Dissonance-Based Intervention to Reduce Ultra-Processed Food Consumption Via Activism Against the Food Industry

The DISRUPT clinical trial will test two different 2-month programs to help adults with overweight/obesity (N=60) reduce their intake of ultra-processed foods (UPFs). Participants will be randomly assigned to receive standard dietary change strategies, cognitive dissonance strategies that engage them in activism against the UPF industry, or both. All participants will attend an introductory educational workshop about UPFs. If they are assigned to receive one or more of these strategies, they will attend weekly group sessions with the relevant intervention content for 7 more weeks. Groups will be held virtually.

Read the detailed description

The DISRUPT clinical trial will test 2-month interventions for reducing ultra processed food (UPF) intake among 60 adults with overweight or obesity (ages 18-70) who frequently consume UPFs. Participants will be randomly assigned to receive a standard dietary change (SDC) intervention (ON/OFF), in which they will receive the typical toolbox of evidence-based methods for changing diet (e.g., meal planning, problem solving, reflecting on the benefits of change) to help them reduce their ultra-processed food intake. Participants will be also randomly assigned to receive a cognitive dissonance intervention (ON/OFF). In this intervention, participants will learn about the harms of the food industry and be engaged in activism against this industry to elicit cognitive dissonance for consuming UPFs. Participants will be randomly assigned to each condition separately (through a 2x2 factorial design, resulting in four possible experimental conditions: 1) Control (both OFF), 2) Standard Dietary Change Condition (SDC ON, Dissonance OFF), 3) Dissonance Condition (SDC OFF, Dissonance ON), and 4) SDC + Dissonance Condition (SDC ON, Dissonance ON).

All participants will receive an introductory educational workshop on UPFs, how to identify them, and their harmful health effects. Participants assigned to receive at least one of the interventions (i.e., SDC, dissonance, or both) will attend weekly group sessions for weeks 2-8.

Aim 1 is to test the isolated and interactive effects of standard behavior change strategies and dissonance-based strategies on treatment outcomes. Participants randomly assigned to the SDC condition and the Dissonance condition, respectively, are expected to have larger reductions in UPF intake, greater improvements in indicators of dietary quality (e.g., added sugar, sodium intake), and more weight loss, compared to those in the control condition. The effect of the SDC + Dissonance condition (vs. the control condition) on treatment outcomes is expected to be synergistic, greater than the additive effect either condition alone.

Aim 2 is to test the hypothesis that having the dissonance intervention ON will attenuate the disparity in treatment outcomes for individuals with socio-structural barriers to healthy eating (i.e., low perceived socioeconomic status, low income, limited access to healthy food, and unhealthy neighborhood food environment).

Being tested
Introductory Educational Workshop, Standard Dietary Change (ON/OFF), Cognitive Dissonance Strategies (ON/OFF)
Keywords
Ultra-Processed Food, Dietary Change, Cognitive Dissonance
Medical subject headings
Obesity, Overweight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Introductory Educational WorkshopBehavioural

    Participants will attend an introductory educational workshop held through videoconferencing software in week 1 of the program. The workshop will teach participants about ultra-processed foods (UPFs) and their negative health effects.

  • Standard Dietary Change (ON/OFF)Behavioural

    Participants randomly assigned to have Standard Dietary Change Strategies ON will attend group sessions with a study coach, during which they will learn standard dietary change strategies such as meal planning, problem solving, and goal setting. Sessions will involve didactics, discussion, and interactive elements to promote greater participant engagement.

  • Cognitive Dissonance Strategies (ON/OFF)Behavioural

    Participants assigned to have the dissonance condition ON will attend weekly virtual group sessions with a coach, during which they will learn about the nefarious efforts of the food industry, including its creation of UPFs to be hyperpalatable and addictive, its predatory and deceptive marketing techniques, and its role in blocking policy change. Special emphasis will be placed on the food industry's exploitation of vulnerable, low-income communities by inundating these neighborhoods with cheap, ultra-rewarding products. Participants will be asked to engage in activities designed to elicit cognitive dissonance for consuming UPFs. Examples include writing letters to Congress urging policy change and creating "elevator pitches" for family and friends.

Study groups in NCT07226336
Study groupRoleWhat they receive
Active Control ConditionActive comparatorParticipants in this condition (Standard Dietary Change OFF, Dissonance OFF) will receive an educational workshop on UPFs and their harmful health effects.
Receives: Behavioral: Introductory Educational Workshop
Standard Dietary Change StrategiesExperimentalParticipants in this condition (Standard Dietary Change ON, Dissonance OFF) will attend an introductory educational workshop about UPFs, then attend weekly group sessions that teach standard dietary change strategies for the next 7 weeks.
Receives: Behavioral: Introductory Educational Workshop; Behavioral: Standard Dietary Change (ON/OFF)
Dissonance StrategiesExperimentalParticipants in this condition (Standard Dietary Change OFF, Dissonance ON) will attend an introductory educational session about UPFs, then attend weekly group sessions in which they will be engaged in cognitive dissonance-inducing activities for the next 7 weeks.
Receives: Behavioral: Introductory Educational Workshop; Behavioral: Cognitive Dissonance Strategies (ON/OFF)
Standard Dietary Change+ Dissonance StrategiesExperimentalParticipants in this condition (Standard Dietary Change ON, Dissonance ON) will attend an introductory educational session about UPFs, then attend weekly group sessions in which they will 1) learn standard dietary change strategies and 2) be engaged in cognitive-dissonance inducing strategies for the next 7 weeks. Groups will be slightly longer to accommodate both intervention strategies.
Receives: Behavioral: Introductory Educational Workshop; Behavioral: Standard Dietary Change (ON/OFF); Behavioral: Cognitive Dissonance Strategies (ON/OFF)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ultra-Processed Food Intake

    Dietary intake will be assessed using the Automated Self-Administered 24-hour Dietary Recall (ASA24), in which participants report all of the food and beverages consumed during the past 24 hours. At each assessment, participants will complete three recalls (two weekdays, one weekend day). To calculate UPF intake, each food entry on the ASA24 will be coded into a NOVA category based on a classification system developed through a collaboration between The University de São Paulo and the National Cancer Institute. UPF intake will be operationalized as the average daily calories that come from UPFs.

    Measured: Baseline, Post-Treatment (2 months)

Secondary outcomes (7)
  1. Weight

    Participants will be asked to provide their current weight by weighing themselves on three consecutive mornings on a digital scale following proper weighing procedures (e.g., in the morning, in a fasted state). The average of the three days of weights will be used.

    Measured: Baseline, Post-Treatment (2 months)

  2. Added Sugar Intake

    Average daily added sugar intake (in grams) will be generated from participants' ASA24 recalls.

    Measured: Baseline, Post-Treatment (2 months)

  3. Saturated Fat Intake

    Average daily saturated fat intake (in grams) will be generated from participants' ASA24 recalls.

    Measured: Baseline; Post-Treatment (2 months)

  4. Sodium Intake

    Average daily sodium intake (in milligrams) will be generated from participants' ASA24 recalls.

    Measured: Baseline; Post-Treatment (2 months)

  5. Fruit Intake

    Average daily fruit intake (in cups) will be generated from participants' ASA24 recalls.

    Measured: Baseline; Post-Treatment (2 months)

  6. Vegetable Intake

    Average daily vegetable intake (in cups) will be generated from participants' ASA24 recalls.

    Measured: Baseline; Post-Treatment (2 months)

  7. Total Calorie Intake

    Average daily calorie intake will be generated from participants' ASA24 recalls.

    Measured: Baseline; Post-Treatment (2 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2025
  2. Study start10 Feb 2026
  3. Primary completion31 Jul 2026
  4. Study completion31 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
59 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07226336
Sponsor's protocol ID
31272E
Other IDs
5P30DK111022
Acronym
DISRUPT
Status last verified
Oct 2026
First submitted
31 Oct 2025
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Identifiable data will be de-identified prior to submission in the public repository to protect research participant privacy and confidentiality. All individual-participant level data will be preserved and shared, as all variables collected are pertinent to scientific questions.

Publications

  • Hagerman C, Choo-Kang D, LaFata E, Rohde P, Butryn M. A cognitive dissonance-based intervention to reduce ultra-processed food intake: Protocol for a pilot randomized controlled trial. Contemp Clin Trials. 2026 Jun;165:108327. doi: 10.1016/j.cct.2026.108327. Epub 2026 Apr 22.

    PubMed 42031230

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Introductory Educational Workshop, Standard Dietary Change (ON/OFF) and Cognitive Dissonance Strategies (ON/OFF) in people with Ultra-Processed Food Intake and Obesity & Overweight, run by Oregon Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ultra-Processed Food Intake (time frame: Baseline, Post-Treatment (2 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07226336, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in